ArticleBMC cancer2024

Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocol.

Alfredo Budillon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.